The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance

Najyya Attia; Khalid Al Noaim; Manal Mustafa; Suliman H. Al Fifi; Ibrahim Al Alwan; Nandu Thalange; Amir Babiker; Najyya Attia; Khalid Al Noaim; Manal Mustafa; Suliman H. Al Fifi; Ibrahim Al Alwan; Nandu Thalange; Amir Babiker

doi:10.1155/pedi/6859764

2025 Volume 2025

Article Contents

Next Previous

RESEARCH ARTICLE Open Access

The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance

More Information

Published online: 20 December 2025
Pediatric Diabetes 2025, Article number: 10.1155/pedi/6859764 (2025) | Cite this article

Rights and permissions
Copyright: © 2025 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Najyya Attia, Khalid Al Noaim, Manal Mustafa, Suliman H. Al Fifi, Ibrahim Al Alwan, Nandu Thalange, Amir Babiker. 2025. The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance. Pediatric Diabetes. 2025:764 doi: 10.1155/pedi/6859764

Najyya Attia, Khalid Al Noaim, Manal Mustafa, Suliman H. Al Fifi, Ibrahim Al Alwan, Nandu Thalange, Amir Babiker. 2025. The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance. Pediatric Diabetes. 2025:764 doi: 10.1155/pedi/6859764

Download PDF

Article Metrics

Article views(80) PDF downloads(26)